136
edits
Translations:Resveratrol/42/en: Difference between revisions
Importing a new version from external source
(Importing a new version from external source) |
(Importing a new version from external source) |
||
| Line 1: | Line 1: | ||
===Resveratrol with Piperine=== | ===Resveratrol with Piperine=== | ||
In 2021 [[Randomized Controlled Trial]], participants receive a single dose of resveratrol 2500 mg, with piperine in 0 mg, 5 mg or 25 mg dose. Despite the observation of piperine coadministration significantly increasing bioavailability ([[Cmax|C<sub>max</sub>]] and [[AUC|AUC)]] of resveratrol in [[C57BL/6 mice|C57BL]] mice, no significant increase in resveratrol or decrease in resveratrol glucuronide could be observed in healthy adults taking 2500 gm of resveratrol with piperine (5 or 25 mg) as compared to resveratrol alone. {{ | In 2021 [[Randomized Controlled Trial]], participants receive a single dose of resveratrol 2500 mg, with piperine in 0 mg, 5 mg or 25 mg dose. Despite the observation of piperine coadministration significantly increasing bioavailability ([[Cmax|C<sub>max</sub>]] and [[AUC|AUC)]] of resveratrol in [[C57BL/6 mice|C57BL]] mice, no significant increase in resveratrol or decrease in resveratrol glucuronide could be observed in healthy adults taking 2500 gm of resveratrol with piperine (5 or 25 mg) as compared to resveratrol alone. {{pmid|32868637}} | ||